NCT00923897View on ClinicalTrials.gov

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 26, 2018

Study Completion Date

September 26, 2018

Conditions
Hepatocellular CarcinomaHepatic Metastasis
Interventions
RADIATION

Palliative RT

Prior to receiving radiation treatment, it is recommended that you take medications to reduce the chance of nausea related to therapy. The treatment will take approximately 30 minutes.

Trial Locations (1)

M5G 2M9

University Health Network, Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00923897 - Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) | Biotech Hunter | Biotech Hunter